This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.
Taylor receiving ACC's 2024 Pamela S. Douglas Award for Diversity and Inclusion at ACC.24 in Atlanta, GA. Herman A. Taylor's, MD, FACC, pioneering career in cardiovascular medicine has been characterized by a lot of change, but his commitment to improving the health of all patients has remained constant, thanks in part to his grandmother who reminded him early in his career that health is one of life's greatest blessings.
(MedPage Today) -- AURORA, Colo. -- Pregnant patients with type 2 diabetes (T2D) treated with semaglutide (Ozempic) had mixed pregnancy outcomes, an observational study found. Among more than 4 million pregnancies, patients exposed to semaglutide.
The 2025 American Heart Association statistics were published recently, and heart disease remains the leading cause of death in the US and globally 1. The good news is that heart disease at younger ages is largely preventable. High cholesterol is a core to heart disease development and can usually be easily managed. With this approach, the future risk of heart disease can be significantly reduced.
Cardiac Output, Cardiac Power Output and Non-Invasive Cardiac Output Monitoring The post Cardiac Output, Cardiac Power Output and Non-Invasive Cardiac Output Monitoring appeared first on All About Cardiovascular System and Disorders.
This month in review spotlights HCPLives coverage of gastroenterology pipeline news, a feature about gastroparesis and migraine, and recent GI research.
Transplantation is lifesaving for many of our patients. Yet an ongoing challenge is how to expand this opportunity to all patients who need a heart in our current setting of limited resources.
The ACC has issued new guidance on practical approaches for arrhythmia monitoring after stroke, offering clinicians tailored strategies to improve post-stroke care by identifying and managing atrial fibrillation (AFib) and other arrhythmias linked to recurrent stroke risk.
The best approach for ablating ventricular tachycardia (VT) targeting right ventricular free wall (RVFW) aneurysms in arrhythmogenic right ventricular cardiomyopathy (ARVC) remains undefined.
In recent years, numerous health care challenges have been tackled, some making headlines, while others quietly escalate under the radar – like polypharmacy. Cardiovascular medications frequently lead this category, often contributing to adverse clinical outcomes, including emergency department visits and hospitalizations. As clinicians, we're caught between evidence-based guidelines and the need for individualized care, a balance that's even more delicate with older adults.
I was sent the ECG in Figure-1 obtained from a previously healthy man his 60s, who contacted EMS ( E mergency M edical S ervices ) for new-onset severe burning CP ( C hest P ain ) that radiated to the jaw and throat. On seeing the ECG in Figure-1 the EMS crew activated the cath lab. QUESTION: Do you agree with this decision by the EMS crew to activate the cath lab?
Pulmonary embolism (PE) continues to challenge clinicians with its complex presentation and potential for rapid deterioration. As the third leading cause of cardiovascular mortality in the U.S.
The number of people in the U.S. who suffered from substance use disorder (SUD) in 2022 hit 48.7 million, of whom 17.3% were >12 years old. The economic burden of opioid use disorder alone was estimated at $1.02 trillion in 2017.
A new multi-society Appropriate Use Criteria (AUC) document focuses on cardiac implantable electronic devices (CIEDs), specifically implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT) and pacing.
Pulmonary embolism (PE) mortality has increased over the past decade and racial and geographic disparities persist. Black women and men have an approximately two-fold higher age-adjusted mortality rate compared with White women and men, respectively.
Read the Health Equity Action Plan ACC's Diversity and Inclusion Hub, including the Heath Equity Resource Center Disparities in life expectancy, driven by race, geography, socioeconomic status and systemic inequities, have widened alarmingly from a 12.6-year gap in 2000 to a staggering 20.4 years by 2021 in the U.S.1 This finding and more come from a new analysis of data from the last two decades.
When a young woman from an affluent Chicago neighborhood came to Annabelle Volgman, MD, FACC, complaining of palpitations before a ski trip, Volgman was shocked to learn the woman had never received an EKG despite months of symptoms. The simple test revealed Wolff-Parkinson-White syndrome, an easily diagnosable and treatable arrhythmia. "I could not believe that anyone would be treated that way," Volgman says.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content